| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/03/2013 | US8524252 Temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof |
| 09/03/2013 | US8524251 Neisseria meningitidis antigens and compositions |
| 09/03/2013 | US8524250 Carrier |
| 09/03/2013 | US8524249 Vaccines for inclusion body hepatitis |
| 09/03/2013 | US8524248 Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma |
| 09/03/2013 | US8524247 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 09/03/2013 | US8524246 Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus |
| 09/03/2013 | US8524243 Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same |
| 09/03/2013 | US8524242 Soluble aggregate, immune tolerance inducer and manufacturing method thereof |
| 09/03/2013 | US8524240 Diagnosis and therapy of hematological malignancies |
| 09/03/2013 | US8524239 Photosensitizing antibody-fluorophore conjugates |
| 09/03/2013 | US8524238 Cancer targets and uses thereof |
| 09/03/2013 | US8524237 Antibodies with immune effector activity and that internalize in endosialin-positive cells |
| 09/03/2013 | US8524236 Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals |
| 09/03/2013 | US8524235 Method for treating coronary artery disease using antibody binding human protein tyrosine phosphatase beta(HPTPbeta) |
| 09/03/2013 | US8524233 Monoclonal antibody and a method thereof |
| 09/03/2013 | US8524232 Methods of treatment using taci-immunoglobulin fusion proteins |
| 09/03/2013 | US8524231 Antigen binding polypeptides |
| 09/03/2013 | US8524230 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
| 09/03/2013 | US8524229 Medicament and a method for regulation of the vascular tone |
| 09/03/2013 | US8524228 Netrin-1 compositions and methods of use thereof |
| 09/03/2013 | US8524227 Anti-IL-TIF antibodies |
| 09/03/2013 | US8524218 Compositions and methods for treatment of neoplastic disease |
| 09/03/2013 | US8524166 Stent and delivery system with reduced chemical degradation including a Chitooligosaccharide |
| 09/03/2013 | CA2736921C Tumour-associated peptides that bind to mhc molecules |
| 09/03/2013 | CA2599322C N protein mutants of porcine reproductive and respiratory syndrome virus |
| 09/03/2013 | CA2551489C Multi plasmid system for the production of influenza virus |
| 09/03/2013 | CA2464372C Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 09/03/2013 | CA2459807C Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/03/2013 | CA2398277C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 09/03/2013 | CA2333931C Polysaccharide vaccine for staphylococcal infections |
| 09/03/2013 | CA2241564C Wsx receptor and ligands |
| 08/29/2013 | WO2013126904A1 Fraction i-iv-1 precipitation of immunoglobins from plasma |
| 08/29/2013 | WO2013126809A1 Prediction of responsiveness to treatment with immunomodulatory therapeutics and method of monitoring abscopal effects during such treatment |
| 08/29/2013 | WO2013126785A1 A system for immunotherapy targeting tumor propagation and progression |
| 08/29/2013 | WO2013126622A1 Methods for displaying polypeptides and uses thereof |
| 08/29/2013 | WO2013126595A1 Methods for treating corneal and conjunctival inflammation and inflammatory disorders |
| 08/29/2013 | WO2013126368A1 Methods, assays, and systems relating to sakt |
| 08/29/2013 | WO2013124419A1 Her3 inhibitor for modulating radiosensitivity |
| 08/29/2013 | WO2013124297A1 Combination of hb-egf binding protein and egfr inhibitor |
| 08/29/2013 | WO2013123591A1 Multimerized single domain antibody ligands of prothrombin as inhibitors of blood and extravascular coagulation |
| 08/29/2013 | WO2013123588A1 Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| 08/29/2013 | WO2013123579A1 Adenovirus-based tuberculosis vaccine and its use |
| 08/29/2013 | WO2013095091A3 Rsv g protein specific antibodies |
| 08/29/2013 | US20130224769 Methods of using chemokine panec-1 antibodies |
| 08/29/2013 | US20130224287 Liposome-Based Construct Comprising a Peptide Modified Through Hydrophobic Moieties |
| 08/29/2013 | US20130224266 Immunogenic composition |
| 08/29/2013 | US20130224251 Variants of group 6 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues |
| 08/29/2013 | US20130224250 Purified Plasmodium and Vaccine Composition |
| 08/29/2013 | US20130224249 Recombinant trypanosoma cruzi cells useful as anti-cancer immune agents |
| 08/29/2013 | US20130224248 Formulation suitable for stabilizing proteins, which is free of mammalian excipients |
| 08/29/2013 | US20130224247 Vaccine against ehrlichia canis |
| 08/29/2013 | US20130224245 Concentration of vaccine antigens without lyophilization |
| 08/29/2013 | US20130224244 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 08/29/2013 | US20130224243 Use of herpes vectors for tumor therapy |
| 08/29/2013 | US20130224242 Methods To Increase Transgene Expression From Bacterial-Based Delivery Systems By Co-Expressing Suppressors Of The Eukaryotic Type I Interferon Response |
| 08/29/2013 | US20130224241 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 08/29/2013 | US20130224238 Gpcr as vaccines or for removing/inhibiting autoantibodies, toxins or ligands binding to the gpcr |
| 08/29/2013 | US20130224235 Potato virus a coat protein-based vaccines for melanoma |
| 08/29/2013 | US20130224233 Immunotherapeutic method for treating prostate cancer |
| 08/29/2013 | US20130224230 Therapeutic uses of glandular kallikrein |
| 08/29/2013 | US20130224228 Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods |
| 08/29/2013 | US20130224227 Novel conjugates of cc-1065 analogs and bifunctional linkers |
| 08/29/2013 | US20130224223 Compositions and Methods for Treating Neurological Disorders |
| 08/29/2013 | US20130224220 ErbB3 BINDING ANTIBODY |
| 08/29/2013 | US20130224218 Methods and Compositions for the Inhibition of Fructokinase |
| 08/29/2013 | US20130224217 Methods of treating complications and disorders associated with g-csf administration |
| 08/29/2013 | US20130224216 Anti-lps enriched immunoglobulin for use in treatment and/or prophylaxis of a pathologic disorder |
| 08/29/2013 | US20130224215 A B Cell Depleting Agent for the Treatment of Atherosclerosis |
| 08/29/2013 | US20130224214 Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis |
| 08/29/2013 | US20130224213 Compositions and Methods for Stabilizing Protein-Containing Formulations |
| 08/29/2013 | US20130224210 Antibodies to matrix metalloproteinase 9 |
| 08/29/2013 | US20130224206 Compositions and methods for stem cell delivery |
| 08/29/2013 | US20130224204 Method of Treatment Based on ATAD2 Inhibitors |
| 08/29/2013 | US20130224203 Pharmaceutical Composition of Recombinant Polyclonal Immunoglobulins |
| 08/29/2013 | US20130224201 Antibodies to il-6 and use thereof |
| 08/29/2013 | US20130224200 Product and Process for Inhibition of Biofilm Development |
| 08/29/2013 | US20130224199 Viral chemokine-antigen fusion proteins |
| 08/29/2013 | US20130224197 Methods for treatment of brain injury utilizing biologics |
| 08/29/2013 | US20130224194 Methods and compositions for diagnostic use in cancer patients |
| 08/29/2013 | US20130224193 Methods and compositions for diagnostic use in cancer patients |
| 08/29/2013 | US20130224192 Method for the prognosis of the progression of cancer |
| 08/29/2013 | US20130224190 Anti-cd19 antibody having adcc and cdc functions and improved glycosylation profile |
| 08/29/2013 | US20130224189 Tweak receptor |
| 08/29/2013 | US20130224188 CD47 Antibodies and Methods of Use Thereof |
| 08/29/2013 | US20130224185 Protein formulation |
| 08/29/2013 | US20130224183 Fraction i-iv-1 precipitation of immunoglobins from plasma |
| 08/29/2013 | US20130224150 IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES |
| 08/29/2013 | US20130224146 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling |
| 08/29/2013 | US20130224145 Complex having tumor vaccine effect, and use thereof |
| 08/29/2013 | US20130224144 Sequential administration of a replication defective adenovirus vector in vaccination protocols |
| 08/29/2013 | US20130224111 Inhibition Of CD69 For Treatment Of Inflammatory Conditions |
| 08/29/2013 | US20130224109 Compositions and methods featuring il-6 and il-21 antagonists |
| 08/28/2013 | EP2631246A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 08/28/2013 | EP2631245A1 Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use |
| 08/28/2013 | EP2630970A1 Cytotoxic immunoglobulin |
| 08/28/2013 | EP2630969A1 Yeast-based vaccines as immunotherapy |
| 08/28/2013 | EP2630968A1 Dendritic cells generated using GM-CSF and interferon alpha and loaded with heat-treated and killed cancer cells |
| 08/28/2013 | EP2630967A1 Vaccine nanotechnology |
| 08/28/2013 | EP2630966A1 Vaccine nanotechnology |